[1]
|
Niu, W., Chen, X.Q., Xu, R.L., et al. (2021) Polysaccharides from Natural Resources Exhibit Great Potential in the Treatment of Ulcerative Colitis: A Review. Carbohydrate Polymers, 254, Article ID: 117189.
https://doi.org/10.1016/j.carbpol.2020.117189
|
[2]
|
Lamb, C.A., Kennedy, N.A., Raine, T., et al. (2019) British Society of Gastroenterology Consensus Guidelines on the Management of Inflammatory Bowel Disease in Adults. Gut, 68, S1-S106. https://doi.org/10.1136/gutjnl-2019-318484
|
[3]
|
Ng, S.C., Shi, H.Y., Hamidi, N., et al. (2018) Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Pop-ulation-Based Studies. Lancet, 390, 2769-2778.
https://doi.org/10.1016/S0140-6736(17)32448-0
|
[4]
|
Jones, G.-R., Lyons, M., Plevris, N., et al. (2019) IBD Prevalence in Lothian, Scotland, Derived by Capture-Recapture Methodology. Gut, 68, 1953-1960. https://doi.org/10.1136/gutjnl-2019-318936
|
[5]
|
Kaplan, G.G. (2015) The Global Burden of IBD: From 2015 to 2025. Nature Reviews Gastroenterology & Hepatology, 12, 720-727. https://doi.org/10.1038/nrgastro.2015.150
|
[6]
|
Kirsner, J.B. (1988) Historical Aspects of Inflammatory Bowel Disease. Journal of Clinical Gastroenterology, 10, 286-297. https://doi.org/10.1097/00004836-198806000-00012
|
[7]
|
Kaplan, G.G. and Ng, S.C. (2017) Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology, 152, 313-321. https://doi.org/10.1053/j.gastro.2016.10.020
|
[8]
|
Quaresma, A.B., Damiao, A.O.M.C., Coy, C.S.R., Magro, D.O., Hino, A.A.F., Valverde, D.A., Panaccione, R., Coward, S.B., Ng, S.C., Kaplan, G.G. and Kotze, P.G. (2022) Temporal Trends in the Epidemiology of Inflammatory Bowel Diseases in the Public Healthcare System in Brazil: A Large Popula-tion-Based Study. The Lancet Regional Health-Americas, 13, Article ID: 100298. https://doi.org/10.1016/j.lana.2022.100298
|
[9]
|
Pasvol, T.J., Horsfall, L., Bloom, S., et al. (2020) Incidence and Prevalence of Inflammatory Bowel Disease in UK Primary Care: A Population-Based Cohort Study. BMJ Open, 10, e036584.
https://doi.org/10.1136/bmjopen-2019-036584
|
[10]
|
Travis, S.P.L., Schnell, D, Krzeski, P., et al. (2013) Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity. Gastroenterology, 145, 987-995. https://doi.org/10.1053/j.gastro.2013.07.024
|
[11]
|
Porter, R.J., Kalla, R. and Ho, G.-T. (2020) Ulcerative Colitis: Recent Advances in the Understanding of Disease Pathogenesis. F1000Research, 9, Article No. 294. https://doi.org/10.12688/f1000research.20805.1
|
[12]
|
Piovani, D., Danese, S., Peyrin-Biroulet, L., et al. (2019) En-vironmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-Analyses. Gastroenterology, 157, 647-659.
https://doi.org/10.1053/j.gastro.2019.04.016
|
[13]
|
Kushkevych, I., Martínková, K., Vítězová, M. and Rittmann, S.K.-M.R. (2021) Intestinal Microbiota and Perspectives of the Use of Meta-Analysis for Comparison of Ulcerative Co-litis Studies. Journal of Clinical Medicine, 10, Article No. 462. https://doi.org/10.3390/jcm10030462
|
[14]
|
Dordević, D., Jančíková, S., Vítězová, M. and Kushkevych, I. (2020) Hydrogen Sulfide Toxicity in the Gut Environment: Me-ta-Analysis of Sulfate-Reducing and Lactic Acid Bacteria in Inflammatory Processes. Journal of Advanced Research, 27, 55-69. https://doi.org/10.1016/j.jare.2020.03.003
|
[15]
|
余玲. 溃疡性结肠炎主要发病机制研究进展综述[J]. 科技视界, 2023(7): 65-68.
https://doi.org/10.3969/j.issn.2095-2457.2023.07.018
|
[16]
|
Kucharzik, T., Dignass, A.U., Atreya, R., et al. (2019) [August 2019-AWMF-Registriernummer: 021-009]. Z Gastroenterol, 57, 1321-1405. https://pubmed.ncbi.nlm.nih.gov/31739378/
|
[17]
|
Cui, G. and Yuan, A. (2018) A Systematic Review of Epidemi-ology and Risk Factors Associated with Chinese Inflammatory Bowel Disease. Frontiers in Medicine, 5, Article 183. https://doi.org/10.3389/fmed.2018.00183
|
[18]
|
Caprilli, R., Viscido, A. and Latella, G. (2007) Current Management of Severe Ulcerative Colitis. Nature Clinical Practice Gastroenterology & Hepatology, 4, 92-101. https://doi.org/10.1038/ncpgasthep0687
|
[19]
|
Vermeire, S., Van Assche, G. and Rutgeerts, P. (2006) Laboratory Markers in IBD: Useful, Magic, or Unnecessary Toys? Gut, 55, 426-431. https://doi.org/10.1136/gut.2005.069476
|
[20]
|
Osada, T., Ohkusa, T., Okayasu, I., et al. (2010) Correlations among Total Colonoscopic Findings, Clinical Symptoms, and Laboratory Markers in Ulcerative Colitis. Journal of Gastroenter-ology & Hepatology, 23, S262-S267.
https://doi.org/10.1111/j.1440-1746.2008.05413.x
|
[21]
|
Vidrich, A., Lee, J., James, E., Cobb, L. and Targan, S. (1995) Segregation of pANCA Antigenic Recognition by DNase Treatment of Neutrophils: Ulcerative Colitis, Type 1 Autoimmune Hepatitis, and Primary Sclerosing Cholangitis. Journal of Clinical Immunology, 15, 293-299. https://doi.org/10.1007/BF01541319
|
[22]
|
Pang, Y., Ruan, H., Wu, D., et al. (2020) Assessment of Clinical Activ-ity and Severity Using Serum ANCA and ASCA Antibodies in Patients with Ulcerative Colitis. Allergy, Asthma & Clin-ical Immunology, 16, Article No. 37.
https://doi.org/10.1186/s13223-020-00433-1
|
[23]
|
阮慧杰. 定量检测血清ANCA和ASCA对UC的临床价值[D]: [硕士学位论文]. 太原: 山西医科大学, 2017.
|
[24]
|
荣雨露, 高海晋, 许翠萍. 定量检测血清抗中性粒细胞胞质抗体对溃疡性结肠炎的临床价值[J]. 中华消化杂志, 2020, 40(10): 697-700
|
[25]
|
Bonneau, J., Dumestre-Perard, C., Rinaudo-Gaujous, M., Genin, C., Sparrow, M., Roblin, X. and Paul, S. (2015) Systematic Review: New Serological Markers (Anti-Glycan, Anti-GP2, Anti-GM-CSF Ab) in the Prediction of IBD Patient Outcomes. Autoimmunity Reviews, 14, 231-245. https://doi.org/10.1016/j.autrev.2014.11.004
|
[26]
|
Sands, B.E. (2015) Biomarkers of Inflammation in Inflammatory Bowel Disease. Gastroenterology, 149, 1275-1285.
https://doi.org/10.1053/j.gastro.2015.07.003
|
[27]
|
张袁露, 庄思慧, 张诗颜. 血细胞相关参数在炎症性肠病患者中的变化及临床意义[J]. 检验医学与临床, 2016, 13(6): 837-839.
|
[28]
|
Torun, S., Tunc, B.D., Suvak, B., et al. (2012) Assessment of Neutrophil-Lymphocyte Ratio in Ulcerative Colitis: A Promising Marker in Predicting Disease Severity. Clinics and Research in Hepatology and Gastroenterology, 36, 491-497. https://doi.org/10.1016/j.clinre.2012.06.004
|
[29]
|
Cherfane, C.E., Gessel, L., Cirillo, D., et al. (2015) Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity. Inflammato-ry Bowel Diseases, 21, 1062-1065.
https://doi.org/10.1097/MIB.0000000000000427
|
[30]
|
田景媛, 罗和生. 中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值在溃疡性结肠炎病情评估中的临床价值[J]. 胃肠病学和肝病学杂志, 2019, 28(3): 291-295.
|
[31]
|
Ipek, S., Cekic, C., Alper, E., et al. (2015) Can Red Cell Distribution Width Be a Marker of Disease Activity in Ulcerative Co-litis? International Journal of Clinical and Experimental Medicine, 8, 13848-13853.
|
[32]
|
Oliveira, A.M., Cardoso, F.S., Rodrigues, C.G., et al. (2016) Can Red Cell Distribution Width Be Used as a Marker of Crohn’s Disease Activity? GE Portuguese Journal of Gastroenterology, 23, 6-12.
https://doi.org/10.1016/j.jpge.2015.10.003
|
[33]
|
Hu, D., Ren, J., Wang, G., et al. (2015) Value of Red Cell Distri-bution Width for Assessing Disease Activity in Crohn’s Disease. The American Journal of the Medical Sciences, 349, 42-45.
https://doi.org/10.1097/MAJ.0000000000000334
|
[34]
|
Khan, K., Schwarzenberg, S.J., Sharp, H., Greenwood, D. and Weisdorf-Schindele, S. (2002) Role of Serology and Routine Laboratory Tests in Childhood Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 8, 325-329.
https://doi.org/10.1097/00054725-200209000-00003
|
[35]
|
Peterson, C.G.B., Sangfelt, P., Wagner, M., et al. (2007) Fecal Levels of Leukocyte Markers Reflect Disease Activity in Patients with Ulcerative Colitis. Scandinavian Journal of Clinical and Laboratory Investigation, 67, 810-820.
https://doi.org/10.1080/00365510701452838
|
[36]
|
Sutherland, A.D., Gearry, R.B. and Frizelle, F.A. (2008) Review of Fecal Biomarkers in Inflammatory Bowel Disease. Diseases of the Colon & Rectum, 51, 1283-1291. https://doi.org/10.1007/s10350-008-9310-8
|
[37]
|
Xue, T.-C., Lan, Z., Xie, X.-Y., et al. (2014) Prognostic Signifi-cance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis. PLOS ONE, 9, e96072. https://doi.org/10.1371/journal.pone.0096072
|
[38]
|
Gökmen, F., Akbal, A., Reşorlu, H., et al. (2015) Neutro-phil-Lymphocyte Ratio Connected to Treatment Options and Inflammation Markers of Ankylosing Spondylitis. Journal of Clinical Laboratory Analysis, 29, 294-298.
https://doi.org/10.1002/jcla.21768
|
[39]
|
Posul, E., Yilmaz, B., Aktas, G. and Kurt, M. (2015) Does Neutro-phil-to-Lymphocyte Ratio Predict Active Ulcerative Colitis? Wiener Klinische Wochenschrift, 127, 262-265. https://doi.org/10.1007/s00508-014-0683-5
|
[40]
|
Celikbilek, M., Dogan, S., Ozbakır, O., et al. (2013) Neutro-phil-Lymphocyte Ratio as a Predictor of Disease Severity in Ulcerative Colitis. Journal of Clinical Laboratory Analysis, 27, 72-76. https://doi.org/10.1002/jcla.21564
|